HOME › DRUGS › GLUCAGON
ACTIVE SUBSTANCE / INN

GLUCAGON

Brand name(s): GVOKE KIT, Baqsimi, Ogluo, GLUCAGON, BAQSIMI, GVOKE VIALDX, GVOKE PFS, GVOKE HYPOPEN
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
ANDA214457
NDA212097
ACTIVE SUBSTANCE
Glucagon
REGULATORS
FDA · EMA
SPONSORS / MAH
Amphastar France Pharmaceuticals, LUPIN LTD, Strongbridge Dublin Limited
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
GLUCAGONANDA214457LUPIN LTDPrescription
BAQSIMINDA210134AMPHASTAR PHARMS INCPrescription
GVOKE KITNDA212097XERISPrescription
GVOKE HYPOPENNDA212097XERISPrescription
GVOKE PFSNDA212097XERISDiscontinued
GVOKE VIALDXNDA212097XERISPrescription
GVOKE PFSNDA212097XERISPrescription
GLUCAGONNDA020928LILLYDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OgluoStrongbridge Dublin LimitedAuthorised11/02/2021Diabetes Mellitus
BaqsimiAmphastar France PharmaceuticalsAuthorised16/12/2019Diabetes Mellitus

FULL INTELLIGENCE ON GLUCAGON

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →